Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
-
Published:2024-01-29
Issue:3
Volume:30
Page:749-761
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Jiang LingxiORCID, Qin Jiejie, Dai YutingORCID, Zhao ShulinORCID, Zhan Qian, Cui PengORCID, Ren Lingjie, Wang Xuelong, Zhang Ruihong, Gao Chenxu, Zhou Yanting, Cai Shangli, Wang Guoqiang, Xie Wenchuan, Tang Xiaomei, Shi Minmin, Ma Fangfang, Liu Jia, Wang Ting, Wang Chaofu, Svrcek Magali, Bardier-Dupas Armelle, Emile Jean FrancoisORCID, de Mestier Louis, Bachet Jean-Baptiste, Nicolle Remy, Cros JeromeORCID, Laurent-Puig PierreORCID, Wei Miaoyan, Song Bin, Jing Wei, Guo ShiweiORCID, Zheng Kailian, Jiang Hui, Wang Huan, Deng Xiaxing, Chen Hao, Tian Qiang, Wang Shengyue, Shi SiORCID, Jin GangORCID, Yin TongORCID, Fang HaiORCID, Chen SaijuanORCID, Shen BaiyongORCID
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Quante, A. S. et al. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med. 5, 2649–2656 (2016). 2. Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014). 3. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7–33 (2021). 4. Park, W., Chawla, A. & O’Reilly, E. M. Pancreatic cancer. JAMA 326, 851 (2021). 5. Conroy, T. et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N. Engl. J. Med. 379, 2395–2406 (2018).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|